RCS - Tristel PLC - Journal of Infection Prevention: TSTL wipes study <Origin Href="QuoteRef">TSTL.L</Origin>

TristelAnnouncement

24/01/2017 07:07

RNS Number : 8777U
Tristel PLC
24 January 2017
Tristel plc
("Tristel" or "the Company")
Tristel's chlorine dioxide wipes are proposed as an alternative to traditional high-level disinfection soaking procedures published in Journal of Infection Prevention
Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, announces that a study conducted at the Centre Hospitalier Rgional Universitaire de Lille, France, compared its Trio Wipes System with a detergent and a peracetic acid disinfectant manufactured by Laboratoires Anios, Hellemmes, France. Anios is France's leading infection prevention company and has recently been acquired by Ecolab Inc. of the United States.
The study found that the wiping procedure with Tristel's chlorine dioxide chemistry displayed more than a 5-log reduction of four strains of bacteria in 30 seconds and a 4-log reduction of bacterial spores in 2 minutes. The soaking procedure with peracetic acid displayed similar results as chlorine dioxide against bacteria but took 10 minutes to do so, and was unable to achieve a 4-log reduction in bacterial spores.
Bacterial spores are considered to be the most resistant organisms to disinfectants and the ability to kill them both in high numbers and quickly is the distinguishing feature of the highest performing products. Peracetic acid is the most widely used high-level disinfectant throughout Europe and soaking an instrument, rather than wiping it, is considered to be the traditional method to disinfect a medical device. The medical device used in the study was a flexible nasendoscope used in Ear, Nose and Throat (ENT) departments. ENT is one of Tristel's main niche markets within hospitals.
The study has been published in the Journal of Infection Prevention (Noureddine Henoun Loukili, Nadine Lemaitre, Benoit Guery, Olivier Gaillot, Dominique Chevalier and Geoffrey Mortuaire (2017) and is titled 'Is a chlorine dioxide wiping procedure suitable for the high-level disinfection of nasendoscopes', Journal of Infection Prevention, pp. 1-6 DOI: 10.1177/1757177416679879). Preliminary results of the study were reported by an RNS Reach on 1 December 2015. 
The Tristel Wipes System is a unique, patented decontamination method for non-lumened scopes and probes. It has been a very significant sales success for the Company globally. Worldwide sales of the Wipes System in the financial year ending June 2016 were 8.7m. 
Paul Swinney, CEO, comments: "We are pleased to see the publication in a peer-reviewed journal of this significant study comparing our Wipes System with peracetic acid, which is the most widely used high-level disinfectant chemistry in Europe and probably the United States also. The results affirm the key advantages of our Wipes over alternative chemistries and disinfection methods. These advantages are the level and speed of kill of the most resistant organisms. This is the twenty-sixth peer-reviewed and published scientific paper featuring Tristel products - a body of evidence of our products' attributes that forms one of our Company's key strengths.
"France is one of our key target markets for growth and this study can only help with this ambition. We sell our products through a distributor in France."
For further information please contact:
Tristel plc
Tel: 01638 721 500
Paul Swinney, Chief Executive Officer

Liz Dixon, Finance Director



Walbrook PR Ltd
Tel: 020 7933 8780 or tristel@walbrookpr.com
Paul McManus
Mob: 07980 541 893
Lianne Cawthorne
Mob: 07584 391 303


finnCap
Tel: 020 7600 1658
Geoff Nash/ Giles Rolls (Corporate Finance)

Alice Lane (Corporate Broking)

This information is provided by RNS
The company news service from the London Stock Exchange
  END
NRABJMITMBITBTR